Back close

Dr. Prashant Mehta

Assistant Professor, General Medicine, School of Medicine Faridabad

Qualification: MD(Medicine), DM(Medical Oncology)
prashantm@fbd.amrita.edu

Bio

Dr Prashant Mehta, a noted Medical Oncologist and a Bone marrow transplant physician, obtained his DM fellowship in Medical oncology and BMT from the apex institute of the country, AIIMS , New Delhi .
He is also an alumnus of the prestigious Maulana Azad Medical College, New Delhi and was a proud recipient of Meghna Krishna Baweja award for all round excellence at MAMC.
He has received the prestigious Prof GS Bhattacharya award for Best all rounder oncologist in India in the year 2021, from Indian Cooperative Oncology Network (ICON).

His primary areas of focus are Acute Leukemia and Lymphoma in children and adults, Bone marrow transplantation, including haploidentical transplants and reduced toxicity transplantation.
He works as Clinical lead for Lymphoid neoplasms, Haploidentical BMT in adults and children , Lung cancer , gynecological cancer , sarcoma and melanoma.
He has been Prinicipal Investigator for more than 20 clinical trials and is a founder member of ‘ Science and Cost ‘ association which works on solutions to improve access to cancer care in India using scientific strategies. He has more than 60 publications in various national and international journals, including book chapters . He is also the Joint editor and web editor for our national oncology journal IJMPO .
Dr Prashant Mehta is credited with the first Bone marrow transplant, first Total Body irradiation based transplant and first MUD transplant in Faridabad region.
His randomized study on dose of Cytarabine during consolidation in Acute Myeloid Leukemia, was selected for oral presentation at ESMO Asia, Singapore. Apart from this he is has a notable presence in various national and international scientific societies.
He is leading the cellular therapy program at Amrita as well as working on making CAR- T cell therapies accessible in India by working in close collaboration with researchers and scientists in India as well as outside. He is skilled in immunotherapy and precision oncology and employs these effectively in suitable scenarios.

Dr Prashant believes that the goal of treatment apart from cure and disease control is happiness and quality of life. He believes in transparency between patient, family and treating Doctor pertaining all aspects of treatment.
The treatment of cancer is complex and associated with different forms of distress for family and patient. Dr Prashant Mehta approaches a patient and disease with the above understanding and hopes to provide comfort and dignity to the patient and the family in difficult situations.

Publications

Journal Article

Year : 2020

Management of Head-and-Neck Cancer during COVID-19 Crisis: A Medical Oncology Perspective

Cite this Research Publication : Pramanik R, Srivastava P, Sharma A, Mehta P, Patel A, Bhethanbhotla S, Biswas B, Batra A, Gupta VG, Das CK, Mahendru S., "Management of head-and-neck cancer during COVID-19 crisis: A medical oncology perspective," Indian Journal of Medical and Paediatric Oncology, 2020;41:153-5

Publisher : Indian Journal of Medical and Paediatric Oncology

Year : 2020

Systemic treatment of gastroesophageal cancer during SARS-CoV2

Cite this Research Publication : Ghosh J, Ganguly S, Biswas B, Dabkara D, Srivastava P, Patel A, Batra A, Mehta P. "Systemic treatment of gastroesophageal cancer during SARS-CoV2," Indian Journal of Medical and Paediatric Oncology | Volume 41, Issue 2, pp: 141-143, March-April 2020 DOI:10.4103/ijmpo.ijmpo_118_20

Publisher : Indian Journal of Medical and Paediatric Oncology

Year : 2020

Gallbladder cancer: Adjuvant and palliative treatment during Covid-19 pandemic in India

Cite this Research Publication : Patel A, Batra A, Mehta P, Sharma A, Sirohi B, Biswas B, Gangulay S, Gupta VG., "Gallbladder cancer: Adjuvant and palliative treatment during Covid-19 pandemic in India," Indian Journal of Medical and Paediatric Oncology, 2020;41:132-4

Publisher : Indian Journal of Medical and Paediatric Oncology

Year : 2020

Breast cancer treatment during the COVID-19 pandemic

Cite this Research Publication : Batra A, Mehta P, Patel A, Bhethanabhotla S, Biswas B, Pramanik R, Das CK., "Breast cancer treatment during the COVID-19 pandemic," Indian Journal of Medical and Paediatric Oncology, 41:135-7; 2020.

Publisher : Indian Journal of Medical and Paediatric Oncology

Year : 2020

How I treat epithelial ovarian cancer during COVID-19 pandemic

Cite this Research Publication : Das CK, Mahindru S, Patel A, Batra A, Biswas B, Mehta P, Pramanik R, Bhethanabhotla S, Gupta VG., "How I treat epithelial ovarian cancer during COVID-19 pandemic," Indian Journal of Medical and Paediatric Oncology, 2020;41:138-40, DOI: 10.4103/ijmpo.ijmpo_112_20

Publisher : Indian Journal of Medical and Paediatric Oncology

Year : 2020

Advisory for cancer patients during the COVID pandemic

Cite this Research Publication : Srivastava P, Tilak T V, Patel A, Das CK, Biswas B, Mahindru S, Pramanik R, Ghosh J, Mehta P., "Advisory for cancer patients during the COVID pandemic," Cancer Research, Statistics, and Treatment, 3(Suppl 1):p S145-S148, April 2020. | DOI: 10.4103/CRST.CRST_125_20

Publisher : Cancer Research, Statistics, and Treatment

Year : 2020

Anti-Her2neu directed therapy in advanced gall bladder cancer: A prospective, multicenter experience from India

Cite this Research Publication : Das CK, Mehta P et al. "Anti-Her2neu directed therapy in advanced gall bladder cancer: A prospective, multicenter experience from India," Journal of Clinical Oncology, 38(15_suppl):e16682-e16682; 2020. DOI:10.1200/JCO.2020.38.15_suppl.e16682

Publisher : Journal of Clinical Oncology

Year : 2020

‘Serious Adverse Events’ faced by clinical trials: Impact of the COVID-19 pandemic

Cite this Research Publication : Parikh PM, Mehta P, Krishna Mohan MVT, Bhattacharya G. S., Govind Babu K. "'Serious Adverse Events' faced by clinical trials: Impact of the COVID-19 pandemic," Indian Journal of Medical and Paediatric Oncology, 2020; 41:127-3, DOI: 10.4103/ijmpo.ijmpo_114_20

Publisher : Indian Journal of Medical and Paediatric Oncology

Year : 2020

Cancer surgery in challenging time of COVID-19 pandemic – A pragmatic approach

Cite this Research Publication : Mahindru S, Das CK, Patel A, Mehta P, Biswas B, Batra A, Bandhopadhyay A. "Cancer surgery in challenging time of COVID-19 pandemic – A pragmatic approach," Indian Journal of Medical and Paediatric Oncology, 2020;41:144-8

Publisher : Indian Journal of Medical and Paediatric Oncology

Year : 2020

How we treat lung cancer during SARS-Cov-2 (COVID-19) pandemic in India?

Cite this Research Publication : Biswas B, Ganguly S, Dabkara D, Ghosh J, Srivastava P, Mehta P, Patel A, Bhethanabhotla S, Batra A, Pramanik R, Gupta VG, Das CK, Mahindru S. "How we treat lung cancer during SARS-Cov-2 (COVID-19) pandemic in India?," Indian Journal of Medical and Paediatric Oncology, 2020;41:149-52. DOI: 10.4103/ijmpo.ijmpo_122_20

Publisher : Indian Journal of Medical and Paediatric Oncology

Year : 2020

Colorectal cancer chemotherapy during COVID-19 pandemic

Cite this Research Publication : Bhethanabhotla S, Pramanik R, Srivastava P, Mehta P, Patel A, Biswas B, et al. "Colorectal cancer chemotherapy during COVID-19 pandemic," Indian Journal of Medical and Paediatric Oncology, 2020; 41(02): 156-160

Publisher : Indian Journal of Medical and Paediatric Oncology

Year : 2020

Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets

Cite this Research Publication : Patel A, Mehta P, Tannock IF, Srivastava P, et al. "Low-Dose Abiraterone in Metastatic Prostate Cancer: Is It Practice Changing? Facts and Facets," Journal of Global Oncology, 2020;6:382-386. doi:10.1200/JGO.19.00341

Publisher : Journal of Global Oncology

Year : 2020

Feasibility of Cyclosporine a Instead of Tacrolimus after Haploidentical Transplantation Using PBSC Grafts with Post-Transplant Cyclophosphamide for Hematological Malignancies

Cite this Research Publication : Prashant Mehta, Rahul Arora, Swati Pabbi. "Feasibility of Cyclosporine a Instead of Tacrolimus after Haploidentical Transplantation Using PBSC Grafts with Post-Transplant Cyclophosphamide for Hematological Malignancies," Biology of Blood and Marrow Transplantation, Volume 26, Issue 3, Supplement, 2020, Page S279, https://doi.org/10.1016/j.bbmt.2019.12.545

Publisher : Biology of Blood and Marrow Transplantation

Year : 2020

Clofarabine-based conditioning for T-cell replete haploidentical hematopoietic stem cell transplant for relapsed/refractory acute leukemia using peripheral blood stem cell grafts and post-transplantation cyclophosphamide

Cite this Research Publication : Mehta P, Arora R. "Clofarabine-based conditioning for T-cell replete haploidentical hematopoietic stem cell transplant for relapsed/refractory acute leukemia using peripheral blood stem cell grafts and post-transplantation cyclophosphamide," Cancer Research, Statistics, and Treatment 3(3):p 614-617, Jul–Sep 2020. | DOI: 10.4103/CRST.CRST_27_20

Publisher : Cancer Research, Statistics, and Treatment

Year : 2020

Has India met this enemy before? From an eternal optimist’s perspective: SARS-CoV-2

Cite this Research Publication : Mehta P, Parikh P, Aggarwal S, Batra A, Patel A, Kulkarni P, et al. "Has India met this enemy before? From an eternal optimist’s perspective: SARS-CoV-2," Indian Journal of Medical Sciences, 2020; 72(1):8-12; Doi: 10.25259/IJMS_30_2020

Publisher : Indian Journal of Medical Sciences

Year : 2020

Primary Tumor Location as a Prognostic and Predictive Marker in Metastatic Colorectal Cancer (mCRC)

Cite this Research Publication : Bahl A, Talwar V, Sirohi B, Mehta P, Arya D, Shrivastava G, Dahiya A and Pavithran K, "Primary Tumor Location as a Prognostic and Predictive Marker in Metastatic Colorectal Cancer (mCRC)," Frontiers in Oncology, 10:964. doi: 10.3389/fonc.2020.00964. (2020)

Publisher : Frontiers in Oncology

Year : 2019

Oncotype DX: Where Does It Stand in India?

Cite this Research Publication : Mehta P et al."Oncotype DX: Where Does It Stand in India?." Journal of Global Oncology, Volume 5, pp. 1–2, 2019, American Society of Clinical Oncology DOI: https://doi.org/10.1200/JGO.19.00151

Publisher : Journal of Global Oncology

Year : 2017

Response to afatinib, after gefitinib and erlotinib, in a patient with advanced adenocarcinoma of lung with brain metastasis: A case report

Cite this Research Publication : Mehta, Prashant; Bhajoni, Pranjit Santonu; Mehta, Swati Pabbi., "Response to afatinib, after gefitinib and erlotinib, in a patient with advanced adenocarcinoma of lung with brain metastasis: A case report," International Journal of Molecular and Immuno Oncology, [S.l.], v. 2, n. 1, p. 22-24, jan. 2017.

Publisher : International Journal of Molecular and Immuno Oncology

Year : 2017

Oncology Gold Standard™ consensus statement on counseling patients for molecular testing and personalized cancer care

Cite this Research Publication : Parikh, Purvish M, Mehta P. et al. "Oncology Gold Standard™ consensus statement on counseling patients for molecular testing and personalized cancer care," International Journal of Molecular and Immuno Oncology, [S.l.], v. 2, n. 2, p. 47-57, jun. 2017

Publisher : International Journal of Molecular and Immuno Oncology

Year : 2016

Fighting cancer through an informed society

Cite this Research Publication : Mehta P, Bhajoni PS, Mehta SP. "Fighting cancer through an informed society," Journal of Social Health and Diabetes, 2016 [cited 2017 Jan 31]; 4:57-66

Publisher : Journal of Social Health and Diabetes

Year : 2014

Isolated Breast Relapse Mimicking Breast Cancer in Elderly Patient with Acute Lymphoblastic Leukemia

Cite this Research Publication : Ajay Gogia, Prashant Mehta, Raja Pramanik, Rajive Kumar, "Isolated Breast Relapse Mimicking Breast Cancer in Elderly Patient with Acute Lymphoblastic Leukemia," Turkish Journal of Hematology, 31:203-204; 2014.

Publisher : Turkish Journal of Hematology

Year : 2014

Chronic lymphocytic leukemia with massive ascites: An unusual presenting manifestation

Cite this Research Publication : Ajay Gogia, Prashant Mehta, Raja Pramanik, Ritu Gupta, "Chronic lymphocytic leukemia with massive ascites: An unusual presenting manifestation," South Asian Journal of Cancer, 2014 Oct- Dec; 3(4): 235–236, doi: 10.4103/2278-330X.142999

Publisher : South Asian Journal of Cancer

Year : 2014

Diffuse large B-cell lymphoma in patients with chronic lymphocytic leukemia: A single center experience

Cite this Research Publication : Gogia A, Raina V, Kumar L, Sharma A, Mehta P, Sharma MC. "Diffuse large B-cell lymphoma in patients with chronic lymphocytic leukemia: A single center experience," South Asian Journal of Cancer, 3:186; 2014. doi: 10.4103/2278-330X.136814

Publisher : South Asian Journal of Cancer

Year : 2014

Nasal NK-T cell lymphoma: 10-year experience of a single institute in India

Cite this Research Publication : Mehta P, Raina V, Kumar L, et al., "Nasal NK-T cell lymphoma: 10-year experience of a single institute in India," Journal of Clinical Oncology, Volume 32, Number 15_suppl https://doi.org/10.1200/jco.2014.32.15_suppl.e1953 (2014)

Publisher : Journal of Clinical Oncology

Year : 2013

Cryptococcal meningitis in chronic lymphocytic leukemia

Cite this Research Publication : Gogia, A; Mehta, P; Raina, V, "Cryptococcal meningitis in chronic lymphocytic leukemia," Indian Journal of Cancer, 50(4): 301; 2013 Oct-Dec. DOI: 10.4103/0019-509X.123633

Publisher : Indian Journal of Cancer

Year : 2012

Severe Eosinophilia in Metastatic Carcinoma Breast: A Rare Paraneoplastic Phenomenon

Cite this Research Publication : Ankur Bahl, Prashant Mehta, and Vinod Raina. "Severe Eosinophilia in Metastatic Carcinoma Breast: A Rare Paraneoplastic Phenomenon," European Journal of Clinical & Medical Oncology 4(3), sept 2012.

Publisher : European Journal of Clinical & Medical Oncology

Year : 2009

A Case Report of Rheumatoid Arthritis Presenting with Right Heart Failure due to Pulmonary Artery Hypertension

Cite this Research Publication : Mehta P, Rohtagi A, Sharma S K. et al. "A Case Report of Rheumatoid Arthritis Presenting with Right Heart Failure due to Pulmonary Artery Hypertension," Max Medical Journal; vol 4,1, 2009, 7-9.

Publisher : Max Medical Journal

Year : 2009

A Case of Mixed Connective Tissue Disease Presenting with Alopecia

Cite this Research Publication : Mehta P, Rohtagi A, Sharma S K. et al. "A case of Mixed connective Tissue Disease presenting with alopecia," Indian Journal of Clinical Practice, Vol. 19, 9, 2009; 37-39.

Publisher : Indian Journal of Clinical Practice

Book Chapter

Year : 2021

PARP inhibitors in hereditary breast and ovarian cancer and other cancers: A review

Cite this Research Publication : Mehta P, Bothra SJ. "PARP inhibitors in hereditary breast and ovarian cancer and other cancers: A review," Advances in Genetics, 2021; 108:35-80. doi: 10.1016/bs.adgen.2021.08.002. Epub 2021 Oct 23. PMID: 34844716.

Publisher : Advances in Genetics

Presentation

Year : 2020

Utility of Serial Measurement of Serum C-Reactive Protein and Procalcitonin in Patients Undergoing HSCT

Cite this Research Publication : Mehta P et al. "Utility of Serial Measurement of Serum C-Reactive Protein and Procalcitonin in Patients Undergoing HSCT," Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR (TCT Meetings), Marriott in Orlando, Florida February 19-23, 2020.

Publisher : Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR (TCT Meetings)

Qualification

MBBS: Maulana Azad Medical College (MAMC, Delhi) (2006)

MD(Medicine):  Lady Hardinge Medical College, Delhi (2010)

DM(Medical Oncology): All India Institute of Medical Sciences (AIIMS, Delhi) (2014)

Visiting Physician fellowship in BMT/Cellular therapy- Fred Hutchinson Cancer research Center, Seattle USA (2016)

Area of Expertise
  • Lymphoma
  • Acute Lymphoblastic Leukaemia
  • Multiple Myeloma
  • T cell replete
  • Haploidentical BMT
  • Reduced toxicity conditioning Chemotherapy
  • Acute Myeloid Leukemia in children and Adults
  • Management of Chronic Myeloid Leukemia in accelerated phase or blast crisis
  • Precision oncology, targeted therapy, immunotherapy
  • Molecular Oncology
  • Lung cancer
  • Sarcomas
  • Ovarian cancer
  • Management of NK/T cell Lymphoma
  • Metronomic treatment of Advanced Head and neck cancer
Awards
  • Recipient of the Prestigious ‘Professor GS Bhattacharya Memorial Award’ for Best All rounder Oncologist in India conferred by the Indian Cooperative Oncology Network (ICON) in 2021
  • Recipient of the prestigious Meghna Krishna Baweja Memorial award 2001-2002 for all round excellence in 1st Professional MBBS (2001-2002) at Maulana Azad Medical College, Delhi
  • Founder Member of Science and Cost Cancer Consortium which is a group of oncologists aiming to improve access to cancer care by utilising scientific principles and drug pharmacokinetics
Admissions Apply Now